FEDERAL COURT OF AUSTRALIA
Aspen Pharma Pty Ltd v H Lundbeck A/S [2013] FCA 324
Citation: Aspen Pharma Pty Ltd v H Lundbeck A/S [2013] FCA 324 Appeal from: Aspen Pharma Pty Ltd and Ors and Commissioner of Patents and H Lundbeck (Joined Party) [2012] AATA 851 Parties: ASPEN PHARMA PTY LTD ACN 004 118 594, SANDOZ PTY LTD ACN 075 449 553, APOTEX PTY LTD ACN 096 916 148 and ALPHAPHARM PTY LTD ACN 002 359 739 v H LUNDBECK A/S and COMMISSIONER OF PATENTS File number: NSD 2236 of 2012 Judge: YATES J Date of judgment: 9 April 2013 Catchwords: PRACTICE AND PROCEDURE – application for a stay of a decision of the Administrative Appeals Tribunal – whether a stay would be appropriate to secure the effectiveness of the hearing and determination of the appeal before the Court – principles relevant to determining whether a stay is appropriate – whether the appeal has some prospect of success – whether the first respondent would lose the benefit of earlier decisions in its favour – relevance of the undesirability of potential parallel proceedings before the Court and the Commissioner of Patents – relevance of potential costs to the applicants in anticipated proceedings before the Commissioner Legislation: Administrative Appeals Tribunal Act 1975 (Cth)
Patents Act 1990 (Cth)
Patents Regulations 1991 (Cth)Cases cited: Alphapharm Pty Ltd v H Lundbeck A/S (2008) 76 IPR 618
Alphapharm Pty Limited & Ors v H. Lundbeck A/S [2011] APO 36; 92 IPR 628
Broadbent v Civil Aviation Safety Authority [1999] FCA 1871
Catena v Australian Securities and Investment Commission [2010] FCA 598
Citrus Queensland Pty Ltd v Sunstate Orchards Pty Ltd [2008] FCA 1867
H Lundbeck A/S v Alphapharm Pty Ltd (2009) 177 FCR 151
Hartnett v Migration Agents Registration Authority [2003] FCA 998
Minister of State for Education and Youth Affairs v Bracken (1984) 6 FCR 197
ReAspen Pharma Pty Ltd and Commissioner of Patents [2012] AATA 851
Secretary, Department of Families, Housing, Community Services and Indigenous Affairs v Mouratidis [2010] FCA 880
Theo v The Secretary, Department of Family Services [2004] FCA 1748Date of hearing: 15 March 2013 Date of publication of reasons: 12 April 2013 Place: Sydney Division: GENERAL DIVISION Category: Catchwords Number of paragraphs: 64 Counsel for the Applicants: Mr C Dimitriadis Solicitor for the Applicants: King & Wood Mallesons Counsel for the First Respondent: Mr R Niall SC Solicitor for the First Respondent: Corrs Chambers Westgarth Counsel for the Second Respondent: The Second Respondent was excused from attendance
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 2236 of 2012
ON APPEAL FROM THE ADMINISTRATIVE APPEALS TRIBUNAL
BETWEEN: ASPEN PHARMA PTY LTD ACN 004 118 594
First ApplicantSANDOZ PTY LTD ACN 075 449 553
Second ApplicantAPOTEX PTY LTD ACN 096 916 148
Third ApplicantALPHAPHARM PTY LTD ACN 002 359 739
Fourth ApplicantAND: H LUNDBECK A/S
First RespondentCOMMISSIONER OF PATENTS
Second Respondent
JUDGE:
YATES J
DATE OF ORDER:
Keep reading for free
Create a free CaseChat account to read Aspen Pharma Pty Ltd v H Lundbeck A/S and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2013] FCA 324
- Decision Date
CaseChat Overview and Summary
The central legal issue in this case is whether the notice of appeal raises questions of law that are arguable and have a reasonable prospect of success. The applicants argue that the AAT erred in its interpretation of sections 223(2)(a) and 70(4) of the Patents Act and regulation 22.11(4)(b) of the Patents Regulations 1991. The first respondent contends that the appeal does not have good prospects of success and that the applicants have not demonstrated the likely quantum of costs that will be incurred if the stay is not granted. The court must balance the desirability of avoiding parallel proceedings against the potential for incurring unnecessary costs.
The court found that the questions of law raised by the applicants were arguable and had some prospect of success. The court was satisfied that the appeal had a reasonable prospect of success and that the applicants had demonstrated the potential for incurring unnecessary and irrecoverable costs if the stay was not granted. The court also noted that the costs of bringing an opposition proceeding should not be substantial and that the preconditions for an extension of term largely involve the fulfilment of straightforward requirements on the part of the patentee. The court concluded that the balance of convenience favoured the granting of a stay.
The court granted the applicants' application for a stay of the AAT's decision pending the outcome of their appeal to the Federal Court. The first respondent's opposition to the granting of a stay was rejected. The court ordered that the AAT's decision be stayed until the appeal to the Federal Court is determined or until further order of the court. The applicants were also granted leave to appeal to the Full Court.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
The first respondent also challenges a number of bases on which the appeal has been brought. It submits that, subject to two exceptions, the applicants’ notice of appeal does not raise questions of law. The two exceptions are questions 1 and 2, which raise, respectively, the proper construction of s 223(2)(a) (considered with s 223(11) of the Act and reg 22.11(4)(b) of the Regulations) and the proper construction of s 70(4) of the Act. Even so, it submits that these questions were correctly determined by the AAT in its favour. It submits that, although not unarguable, the appeal does not enjoy good prospects of success and that this is a relevant consideration in determining how the discretion should be exercised in the present application.CONSIDERATION The critical issue in the appeal is whether s 223(2)(a) of the Act, read in light of s 223(11) and reg 22.11(4)(b), confers the power to extend time for filing, during the term of the patent, an application for an extension of term under s 70(1) of the Act. I am satisfied, for the purposes of this application, that this question is raised as a question of law by the notice of appeal and that the construction for which the applicants contend is arguable. I am satisfied that the appeal has some prospect of success. In saying this, I do not wish to be taken as implying that, in my view, the construction favoured by the Commissioner and the AAT is wrong. It is a construction that is available, for the reasons expressed by the AAT. It will be a matter for the Full Court to determine the correctness of that construction. It is not necessary for me to discuss each and every one of the other questions that are said to arise on the appeal, beyond noting, in a summary way, that I am not persuaded that, considered cumulatively, those grounds substantially add to the applicants’ prospects of success in the appeal. It seems to me that the fate of the present application really rests in balancing the other considerations which the parties have advanced for and against the granting of a stay. At face value, the contention that there should not be parallel proceedings before the Commissioner while the appeal to this Court is pending, is persuasive. Absent other considerations, the taking of further steps in the extension of term application – dependent as that application is upon the proper exercise of the power under s 223(2)(a) of the Act – may be undesirable, to the extent that it is possible that unnecessary and irrecoverable costs will be incurred. However, the following matters should be noted. First, insofar as the applicants rely on prejudice to themselves, they have placed no evidence before the Court as to the likely quantum of the costs that will be incurred. Thus, their concerns find no material expression beyond the construct of their contention. I accept that if the anticipated opposition proceedings take their course, the steps which the applicants have identified will need to be taken and that, as a consequence, costs will be incurred. However, the preconditions for an extension of term largely involve the fulfilment of somewhat prosaic requirements on the part of the patentee which, normally, do not admit of significant debate. The costs of bringing an opposition proceeding should not be substantial.